Sheng‐Long Ye
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
- Hepatology 39
- Hepatocellular Carcinoma Treatment and Prognosis 34
-
- Cancer, Hypoxia, and Metabolism 13
- Cancer Genomics and Diagnostics 9
- Co-authors
- Zhao–You TangYinkun LiuLun–Xiu QinZhenggang RenTong‐Chun XueJia FanZhi-Quan WuRongxin Chen
- Journals
- Journal of Cancer Research and Clinical Oncology (16 papers)World Journal of Gastroenterology (5 papers)Journal of Clinical Oncology (4 papers)Tree Physiology (3 papers)Oncology Reports (3 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Sheng‐Long Ye
124 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 114
- Hepatology 1.5k
- Cancer Research 897
- Oncology 1.0k
- Molecular Biology 1.5k
- Pathology and Forensic Medicine 376
Countries citing papers authored by Sheng‐Long Ye
This map shows the geographic impact of Sheng‐Long Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Long Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Long Ye more than expected).
Fields of papers citing papers by Sheng‐Long Ye
This network shows the impact of papers produced by Sheng‐Long Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Long Ye. The network helps show where Sheng‐Long Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng‐Long Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2022 | 17 | |
| 3 | 2021 | 41 | |
| 4 | 2018 | 35 | |
| 5 | 2017 | 3 | |
| 6 | 2017 | 24 | |
| 7 | 2016 | 36 | |
| 8 | 2015 | 6 | |
| 9 | 2015 | 33 | |
| 10 | 2015 | 44 | |
| 11 | 2013 | 16 | |
| 12 | Experimental research on inhibition of interferon-alfa on hepatocellular carcinoma reinforced by Chinese herbal compound Songyou Yin. | 2011 | 1 |
| 13 | Role of proteins of missing in metastasis in cancer initiation and progression | 2010 | 1 |
| 14 | 2006 | 118 | |
| 15 | 2005 | 14 | |
| 16 | 2004 | 386 | |
| 17 | 2003 | 31 | |
| 18 | 2001 | 2 | |
| 19 | Relationship between type IV collagenase and the invasion and metastasis of hepatocellular carcinoma | 1999 | 2 |
| 20 | 1999 | 13 |
About Sheng‐Long Ye
Sheng‐Long Ye is a scholar working on Hepatology, Cancer Research, Biotechnology, Immunology and Oncology, having authored 125 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (34 papers), Immunotherapy and Immune Responses (14 papers), Cancer Mechanisms and Therapy (14 papers), Cancer Research and Treatments (13 papers), Cancer, Hypoxia, and Metabolism (13 papers), Liver Disease Diagnosis and Treatment (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Hepatology (1.5k citations), Cancer Research (897 citations), Oncology (1.0k citations), Molecular Biology (1.5k citations) and Pathology and Forensic Medicine (376 citations). Sheng‐Long Ye has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Zhao–You Tang, Yinkun Liu, Lun–Xiu Qin, Zhenggang Ren, Tong‐Chun Xue, Jia Fan, Zhi-Quan Wu, Rongxin Chen, Boheng Zhang and Zhao–You Tang. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, World Journal of Gastroenterology, Journal of Clinical Oncology, Tree Physiology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.